Carlyle Group Inc.

NASDAQ: CG · Real-Time Price · USD
39.29
0.65 (1.68%)
At close: May 01, 2025, 12:08 PM
1.68%
Bid 39.25
Market Cap 14.18B
Revenue (ttm) 3.94B
Net Income (ttm) 1.02B
EPS (ttm) 2.77
PE Ratio (ttm) 14.18
Forward PE 8.27
Analyst Hold
Ask 39.37
Volume 681,683
Avg. Volume (20D) 3,513,106
Open 38.98
Previous Close 38.64
Day's Range 38.36 - 39.88
52-Week Range 33.02 - 57.50
Beta 1.71

About CG

The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and ventur...

IPO Date May 3, 2012
Employees 2,300
Stock Exchange NASDAQ
Ticker Symbol CG
Full Company Profile

Analyst Forecast

According to 17 analyst ratings, the average rating for CG stock is "Hold." The 12-month stock price forecast is $48, which is an increase of 22.17% from the latest price.

Stock Forecasts

Next Earnings Release

Carlyle Group Inc. is scheduled to release its earnings on May 8, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
+6.01%
Shares of companies within the broader financial s... Unlock content with Pro Subscription
2 weeks ago
-4.65%
Carlyle Group and Bluebird Bio shares are trading lower. The company, along with SK Capital Partners, announced that the Beacon merger subsidiary has extended the expiration date to acquire the outstanding shares of Bluebird Bio.